Literature DB >> 7987813

Detection of methylcytosine-rich heterochromatin on banded chromosomes. Application to cells with various status of DNA methylation.

C Montpellier1, C A Burgeois, N Kokalj-Vokac, M Muleris, A Niveleau, C Reynaud, A Gibaud, B Malfoy, B Dutrillaux.   

Abstract

A procedure including incorporation of 5-bromodeoxyuridine (BrdU) in DNA and a thermal denaturation step was developed to obtain both R-banding and efficient binding of anti-5-methylcytosine antibodies on metaphase chromosomes. BrdU incorporation improved the efficiency of antibody binding disclosed by immunofluorescence staining. This method allowed semiquantitative analysis of the antibody binding sites on straightforward characterized metaphase chromosomes and was applied to normal human lymphocytes and lymphoblastoid cell lines for which DNA methylation status had been previously analyzed. A correlation was established between level of DNA methylation and the semiquantitative estimate of antibody fixation. This procedure can be used to study DNA methylation on metaphase chromosomes in transformed and cancerous cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987813     DOI: 10.1016/0165-4608(94)90052-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Cytological investigation of Haplopappus gracilis (Nutt.) Gray: 5-methylcytosine-rich regions, fluorochrome banding and chromatin sensitivity to DNase I digestion.

Authors:  M Ruffini Castiglione; M Frediani; G Venora; R Cremonini
Journal:  Protoplasma       Date:  2008-07-10       Impact factor: 3.356

Review 2.  Histone modifications and nuclear architecture: a review.

Authors:  Eva Bártová; Jana Krejcí; Andrea Harnicarová; Gabriela Galiová; Stanislav Kozubek
Journal:  J Histochem Cytochem       Date:  2008-05-12       Impact factor: 2.479

3.  Epigenetic modifications in sex heterochromatin of vole rodents.

Authors:  I Romero-Fernández; C S Casas-Delucchi; M Cano-Linares; M Arroyo; A Sánchez; M C Cardoso; J A Marchal
Journal:  Chromosoma       Date:  2014-12-21       Impact factor: 4.316

4.  DNA methylation of the extraembryonic tissues: an in situ study on human metaphase chromosomes.

Authors:  N Kokalj-Vokac; A Zagorac; M Pristovnik; C A Bourgeois; B Dutrillaux
Journal:  Chromosome Res       Date:  1998-04       Impact factor: 5.239

5.  New sites of methylcytosine-rich DNA detected on metaphase chromosomes.

Authors:  A Barbin; C Montpellier; N Kokalj-Vokac; A Gibaud; A Niveleau; B Malfoy; B Dutrillaux; C A Bourgeois
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

6.  DNA methylation of the X chromosomes of the human female: an in situ semi-quantitative analysis.

Authors:  J Bernardino; E Lamoliatte; M Lombard; A Niveleau; B Malfoy; B Dutrillaux; C A Bourgeois
Journal:  Chromosoma       Date:  1996-04       Impact factor: 4.316

7.  Cytological evidence for 5-azacytidine-induced demethylation of the heterochromatic regions of human chromosomes.

Authors:  A de Capoa; F Menendez; I Poggesi; P Giancotti; C Grappelli; M R Marotta; M Di Leandro; C Reynaud; A Niveleau
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

8.  Methylated-rich regions and tandem repeat arrays along the chromosome complement of Colpodium versicolor (Stev.) Schmalh.

Authors:  Monica Ruffini Castiglione; Violet Kotseruba; Roberto Cremonini
Journal:  Protoplasma       Date:  2009-07-21       Impact factor: 3.356

9.  Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors.

Authors:  Lina Ghabreau; Jean Paul Roux; Alain Niveleau; Bernard Fontanière; Cédric Mahe; Moncef Mokni; Lucien Frappart
Journal:  Virchows Arch       Date:  2004-06-19       Impact factor: 4.064

10.  Common methylation characteristics of sex chromosomes in somatic and germ cells from mouse, lemur and human.

Authors:  J Bernardino; M Lombard; A Niveleau; B Dutrillaux
Journal:  Chromosome Res       Date:  2000       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.